About the Company
milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MIST News
Milestone Pharmaceuticals Inc (MIST)
On Tuesday, Piper Sandler adjusted its outlook on Milestone Pharmaceuticals (NASDAQ:MIST), reducing the stock price target from $6.00 to $5.00 while maintaining an Overweight ...
Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants
MONTREAL and CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company ...
Why Milestone Pharmaceuticals (MIST) Stock Is Rising
Milestone Pharmaceuticals Inc (NASDAQ:MIST) shares are trading higher by 19.4% to $2.03 Monday morning after the company announced plans to resubmit the New Drug Application (NDA) for etripamil to ...
Milestone Pharmaceuticals Earns Buy Rating on Strong Regulatory and Financial Outlook
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research Report), with a price target of $25.00. Patrick Trucchio ...
Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
MONTREAL and CHARLOTTE, N.C., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced plans to resubmit the New Drug Application (NDA) for etripamil to ...
AstraZeneca to buy Canadian cancer treatment developer Fusion Pharmaceuticals
HAMILTON — Canadian cancer treatment developer Fusion Pharmaceuticals Inc. has signed a deal to be bought by AstraZeneca ... is payable upon the achievement of a specified regulatory milestone. Fusion ...
Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants
MONTREAL and CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the ...
Milestone Pharmaceuticals Inc MIST
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...